期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JOURNAL OF CLINICAL ONCOLOGY LetPub Score 9.9
50 ratings
Rate
Reputation 9.9 Influence 9.9 Speed 9.1 | ||||||||||||||||||||
期刊簡稱 | J CLIN ONCOL | ||||||||||||||||||||
ISSN | 0732-183X | ||||||||||||||||||||
E-ISSN | 1527-7755 | ||||||||||||||||||||
h-index | 494 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 2.40%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://jco.ascopubs.org/ | ||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/JCO-ASCOPUBS | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | American Society of Clinical Oncology | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 隔週刊行 | ||||||||||||||||||||
創刊年 | 1983 | ||||||||||||||||||||
每年文章數 | 479每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 29.96% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0732-183X%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 20% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 下一頁 末頁 (頁 | |
[JOURNAL OF CLINICAL ONCOLOGY] 的評論 | 撰寫評論 |
作者: Adelaide Lawson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-26 19:23:11 評論於 The submission period usually falls between 3-6 months, so your three months is also normal.(0) 讚! | Adelaide Lawson |
作者: Adelaide Lawson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-26 08:53:39 評論於 It may be a browser issue, field highlighting issue, system setting issue, or even a formatting issue. If you have made sure that all required fields are correctly filled in and still encounter the problem, try registering with a different browser. If the issue persists, you can contact the journal's editorial office or technical support for assistance.(0) 讚! | Adelaide Lawson |
作者: 平原依凝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-01 09:34:21 評論於 Why does it keep saying "Please correct the highlighted fields below." when I've filled in all the required fields? Help!!!(0) 讚! | 平原依凝 |
作者: 一只小鲤鱼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-25 17:58:14 評論於 I received a "Decision in Process" status just two days after submitting my paper. It has been four days now and I have not received a rejection notice yet. Did you also have a "Decision in Process" stage when you submitted your paper?(0) 讚! | 一只小鲤鱼 |
作者: bosy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-23 18:56:53 評論於 How are you doing?(0) 讚! | bosy |
作者: 是志丹吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-19 12:14:27 評論於 Review speed: 3.0 | Submission hit rate: 25.0 Emphasis on research directions: ASCO; tumor; solid tumor Experience sharing: JOURNAL OF CLINICAL ONCOLOGY, 2023 impact factor is 42.1 points, which is basically the same as LANCET ONCOLOGY, they are on par, and still in a leading position in the field of oncology. LANCET ONCOLOGY has an impact factor of 41.6 in 2023, which is overall good. CA-A CANCER JOURNAL FOR CLINICIANS, 503.1, dominates with one article, without considering Nature Reviews Clinical Oncology 81.3, mainly publishing reviews, ANNALS OF ONCOLOGY, 56.7 mainly reviews CANCER CELL 48.8, mainly publishes translational medicine, of course, starting from the past two years, also published a few clinical trial articles. Moving down, Cancer Discovery, 29.7, also publishes articles on basic research and translational medicine, which are far from clinical. Journal of Hematology & Oncology 29.5 is a comprehensive journal on hematologic tumors and solid tumors, impressive Molecular Cancer 27.7 is also related to tumor translational medicine.(0) 讚! | 是志丹吖 |
作者: 西域妙绿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-06 13:00:17 評論於 How long have you been under review?(0) 讚! | 西域妙绿 |
作者: 西域妙绿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-28 11:02:25 評論於 29 days left(0) 讚! | 西域妙绿 |
作者: 西域妙绿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-25 13:14:29 評論於 26 days to go, keep it up! ?(0) 讚! | 西域妙绿 |
作者: 西域妙绿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-16 14:44:19 評論於 Under review for 17 days(0) 讚! | 西域妙绿 |
作者: 西域妙绿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-05 16:31:08 評論於 Focused research direction: Tumor clinical experience sharing: Under review for 7 days, hoping for good luck ??(0) 讚! | 西域妙绿 |
作者: 雨双Sama 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-29 23:52:53 評論於 Is Under Review done by external audit?(0) 讚! | 雨双Sama |
作者: 光明谷玉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-15 22:20:19 評論於 Have you successfully registered in the highlighted area?(0) 讚! | 光明谷玉 |
作者: 光明谷玉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-15 12:11:23 評論於 Have you successfully registered?(0) 讚! | 光明谷玉 |
作者: 是志丹吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-29 17:18:36 評論於 Review speed: 3.0 | Submission hit rate: 25.0 Emphasized research directions: Lung cancer; Breast cancer; Colorectal cancer Experience sharing: Impact Factor 45.3 in 2023, slightly lower than Lancet Oncology, which is at a normal level!!(0) 讚! | 是志丹吖 |
作者: 幽花碧霜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-27 20:10:00 評論於 Pretty high priority, no procrastination(0) 讚! | 幽花碧霜 |
作者: 稻妻怜蕾 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-27 19:09:54 評論於 Is it?(0) 讚! | 稻妻怜蕾 |
作者: Humphrey Senior 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-13 11:29:59 評論於 Does it mean a rejection if there is no "under review" status?(0) 讚! | Humphrey Senior |
作者: 一吃就胖小恨蕊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-04 18:43:43 評論於 How long does it take for your manuscript to be reviewed?(0) 讚! | 一吃就胖小恨蕊 |
作者: 北风爱梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-22 13:06:35 評論於 Endure for four days, do not reject the manuscript, and you will succeed(0) 讚! | 北风爱梅 |
作者: 是志丹吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-11 08:51:00 評論於 JCO still focuses on conducting trials(0) 讚! | 是志丹吖 |
作者: 浩博小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-07 11:00:31 評論於 Why hasn't the status of the letter I submitted changed after a week?(0) 讚! | 浩博小哥哥 |
作者: 浩博小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-04 15:26:13 評論於 Why does the status of this submission not change?(0) 讚! | 浩博小哥哥 |
作者: Gabriel Joule 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-09 16:10:04 評論於 Hello, do you know how to solve this? I always get a prompt to modify the highlighted area when I register(0) 讚! | Gabriel Joule |
作者: 韦陀飞虎 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-05 13:46:35 評論於 Can I leave a review?(0) 讚! | 韦陀飞虎 |
首頁 上一頁 1 2 3 4 下一頁 末頁 (頁 |
Contact us